Worldwide incidence, molecular epidemiology and mutations implicated in fluoroquinolone-resistant Streptococcus pneumoniae:: data from the global PROTEKT surveillance programme

被引:98
作者
Canton, R
Morosini, M
Enright, MC
Morrissey, I
机构
[1] GR Micro Ltd, London NW1 3ER, England
[2] Univ Bath, Bath BA2 7AY, Avon, England
[3] Hosp Ramon & Cajal, E-28034 Madrid, Spain
关键词
multilocus sequence typing; Spain(23F)-1; topoisomerase mutations; fluoroquinolone resistance;
D O I
10.1093/jac/dkg465
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objectives: To analyse the mutations and epidemiology associated with fluoroquinolone-resistant pneumococci collected as part of the PROTEKT global surveillance programme during 1999-2000. Methods: Sixty-nine centres in 25 countries submitted a total of 3362 Streptococcus pneumoniae isolates, for which the MICs of antimicrobial agents were determined using NCCLS methodology. Results: Levofloxacin resistance was low overall (1% worldwide), with higher rates in: Hong Kong (14.3%), South Korea (2.9%), USA (1.8%), Mexico (1.5%), Canada (1.4%) and Japan (1.3%). Levofloxacin resistance was very low or absent in European countries, and absent in Australia. Worldwide, there was a total of 35 levofloxacin-resistant isolates, of which 22 (63%) were resistant and 10 (29%) were intermediate to moxifloxacin. All levofloxacin-resistant isolates were susceptible to telithromycin (less than or equal to0.5 mg/L), linezolid (less than or equal to2 mg/L) and quinupristin/dalfopristin (less than or equal to1 mg/L). One or more mutations in the topoisomerase genes were identified in all levofloxacin-resistant isolates; most of these isolates (33/35) had a mutation in one of the DNA gyrase encoding genes (gyrA, gyrB) and one of the topoisomerase IV encoding genes (parC, parE). Eighteen (51%) isolates carried the same combination of amino acid substitutions: Ser-81-->Phe in GyrA and Ser-79-->Phe in ParC. Isolates displaying a levofloxacin MIC of 2-4 mg/L generally had no mutation or one mutation in either a DNA gyrase or a topoisomerase IV gene, although most mutations were in parC. Conclusions: Most levofloxacin-resistant isolates possess two mutations (one in DNA gyrase and one in topoisomerase IV). Although multilocus sequence typing demonstrated that most of these isolates were unrelated, 12 (34%) were the Spain(23F)-1 clone: 10 from Hong Kong and one each from Saskatchewan, Canada and Sao Paulo, Brazil.
引用
收藏
页码:944 / 952
页数:9
相关论文
共 39 条
  • [11] A multilocus sequence typing scheme for Streptococcus pneumoniae:: identification of clones associated with serious invasive disease
    Enright, MC
    Spratt, BG
    [J]. MICROBIOLOGY-UK, 1998, 144 : 3049 - 3060
  • [12] Trends in the antimicrobial susceptibility of bacterial respiratory tract pathogens - Findings of the Alexander Project 1992-1996
    Felmingham, D
    Washington, J
    [J]. JOURNAL OF CHEMOTHERAPY, 1999, 11 : 5 - 21
  • [13] The need for antimicrobial resistance surveillance
    Felmingham, D
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2002, 50 : 1 - 7
  • [14] Finch R G, 2000, J Chemother, V12 Suppl 1, P5
  • [15] Fluit A C, 1999, Int J Infect Dis, V3, P153, DOI 10.1016/S1201-9712(99)90037-1
  • [16] Emergence of extremely high penicillin and cefotaxime resistance and high-level levofloxacin resistance in clinical isolates of Streptococcus pneumoniae in Hungary
    Glatz, K
    Szabó, R
    Szabó, G
    Boriszova, D
    Rozgonyi, F
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2001, 48 (05) : 731 - 734
  • [17] SUPERINFECTION WITH STREPTOCOCCUS-PNEUMONIAE DURING THERAPY WITH CIPROFLOXACIN
    GORDON, JJ
    KAUFFMAN, CA
    [J]. AMERICAN JOURNAL OF MEDICINE, 1990, 89 (03) : 383 - 384
  • [18] Emergence of fluoroquinolone resistance among multiply resistant strains of Streptococcus pneumoniae in Hong Kong
    Ho, PL
    Que, TL
    Tsang, DNC
    Ng, TK
    Chow, KH
    Seto, WH
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (05) : 1310 - 1313
  • [19] Increasing resistance of Streptococcus pneumoniae to fluoroquinolones:: results of a Hong Kong multicentre study in 2000
    Ho, PL
    Yung, RWH
    Tsang, DNC
    Que, TL
    Ho, M
    Seto, WH
    Ng, TK
    Yam, WC
    Ng, WWS
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2001, 48 (05) : 659 - 665
  • [20] Target site modifications and efflux phenotype in clinical isolates of Streptococcus pneumoniae from Hong Kong with reduced susceptibility to fluoroquinolones
    Ho, PL
    Yam, WC
    Que, TL
    Tsang, DNC
    Seto, WH
    Ng, TK
    Ng, WS
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2001, 47 (05) : 655 - 658